Aug 13, 2020
Regulus Therapeutics Reports Second Quarter 2020 Financial Results and Recent Updates
Jun 18, 2020
Aridis Pharmaceuticals to Discuss APEX(TM) in Virtual Fireside Chat Hosted by Cantor Fitzgerald on June 25th
Jun 15, 2020
Black Health Matters To Launch New Kidney Disease Channel
May 28, 2020
OrPro Therapeutics Advances a New Inhalation Treatment Approach for COVID-19
May 28, 2020
Microbion Awarded up to $17.1 Million from CARB-X and the Cystic Fibrosis Foundation to Develop Inhaled Antimicrobial for Chronic Respiratory Infections in CF
May 25, 2020
4DMedical's Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health
May 14, 2020
Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent Updates
May 12, 2020
Aridis Pharmaceuticals Announces First Quarter 2020 Results
Apr 30, 2020
US Societal Economic Burden of an Inherited Kidney Disease Estimated at $7-10 Billion
Apr 23, 2020
U.S. FDA grants orphan drug designation to AmideBio's glucagon analog for the treatment of congenital hyperinsulinism
Apr 22, 2020
Cardiologs Announces Clinical Study to Monitor Cardiac Safety of COVID-19 Patients Via Smartwatches
Mar 17, 2020
EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus
Mar 12, 2020
Regulus Reports Fourth Quarter and Year-End 2019 Financial Results and Recent Updates
Mar 10, 2020
Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
Mar 06, 2020
Aridis Pharmaceuticals to Postpone Investor Day Due to Coronavirus Concerns
Mar 04, 2020
Insmed Announces Publication Discussing the Clinical Management of Common Respiratory Events Associated with ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in the Journal Open Forum Infectious Disease
Mar 04, 2020
Aridis Pharmaceuticals Provides Update on Investor Day Featuring Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
Feb 24, 2020
Proteostasis Therapeutics and CF Europe Announce Completion of Patient Enrollment for CHOICES, the First-Ever Personalized Medicine-Based Study in Cystic Fibrosis
Feb 18, 2020
Aridis Pharmaceuticals to Host Investor Day Showcasing APEX(TM) Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
Jan 13, 2020
Proteostasis Therapeutics Regulatory Update Following Scientific Advice Meeting with MHRA